Literature DB >> 9465907

Molecular cloning of a novel gene similar to myeloid antigen CD33 and its specific expression in placenta.

Y Takei1, S Sasaki, T Fujiwara, E Takahashi, T Muto, Y Nakamura.   

Abstract

We have isolated a novel gene that encodes a protein sharing significant similarity with myeloid antigen CD33. The complete cDNA contains an open reading frame of 1,326 nucleotides encoding 442 amino acids. The deduced amino acid sequence indicates that this molecule belongs to the immunoglobulin (Ig) superfamily and is likely to be a new member of the sialoadhesin sub-family. It is composed of three Ig-like domains; its high degree of similarity to CD33 (70% identity) in the first and second of these domains implies that the placenta-specific gene product is likely to be associated with cell-cell interaction. Northern-blot analysis revealed transcripts of four distinct sizes, 7.5 kb, 5.0 kb, 4.1 kb, and 2.0 kb, specifically in the placenta. Consequently, we termed this gene CD33L (CD33 antigen-like). An alternatively-spliced transcript encoding a 342-amino-acid peptide which lacked the transmembrane region and the cytoplasmic tail was also isolated. We mapped CD33L by fluorescence in situ hybridization (FISH) to human chromosome 19q13.3, where the CD33 gene is also located.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9465907     DOI: 10.1159/000134676

Source DB:  PubMed          Journal:  Cytogenet Cell Genet        ISSN: 0301-0171


  9 in total

1.  Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor.

Authors:  J Munday; S Kerr; J Ni; A L Cornish; J Q Zhang; G Nicoll; H Floyd; M G Mattei; P Moore; D Liu; P R Crocker
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

2.  Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells.

Authors:  C Vitale; C Romagnani; M Falco; M Ponte; M Vitale; A Moretta; A Bacigalupo; L Moretta; M C Mingari
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

Review 3.  Basic and clinical immunology of Siglecs.

Authors:  Stephan von Gunten; Bruce S Bochner
Journal:  Ann N Y Acad Sci       Date:  2008-11       Impact factor: 5.691

4.  Siglec-6 expression is increased in placentas from pregnancies complicated by preterm preeclampsia.

Authors:  Kristen K Rumer; Jill Uyenishi; M Camille Hoffman; Barbra M Fisher; Virginia D Winn
Journal:  Reprod Sci       Date:  2012-11-20       Impact factor: 3.060

5.  Soluble Siglec-14 glycan-recognition protein is generated by alternative splicing and suppresses myeloid inflammatory responses.

Authors:  Po-Chun Jimmy Huang; Penk-Yeir Low; Iren Wang; Shang-Te Danny Hsu; Takashi Angata
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

6.  Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells.

Authors:  M Falco; R Biassoni; C Bottino; M Vitale; S Sivori; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-09-20       Impact factor: 14.307

7.  Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.

Authors:  Piper A Robida; Clayton H Rische; Netali Ben-Baruch Morgenstern; Rethavathi Janarthanam; Yun Cao; Rebecca A Krier-Burris; Wouter Korver; Alan Xu; Thuy Luu; Julia Schanin; John Leung; Marc E Rothenberg; Joshua B Wechsler; Bradford A Youngblood; Bruce S Bochner; Jeremy A O'Sullivan
Journal:  Cells       Date:  2022-03-28       Impact factor: 7.666

Review 8.  A lesson for cancer research: placental microarray gene analysis in preeclampsia.

Authors:  Frank Louwen; Cornelia Muschol-Steinmetz; Joscha Reinhard; Anke Reitter; Juping Yuan
Journal:  Oncotarget       Date:  2012-08

Review 9.  Multiple changes in sialic acid biology during human evolution.

Authors:  Ajit Varki
Journal:  Glycoconj J       Date:  2008-09-07       Impact factor: 2.916

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.